$CTTH

CTT PHARMACEUTICAL HOLDINGS, INC.

No enriched coverage for $CTTH in the last 7 days.

$959
—
CTT PHARMACEUTICAL HOLDINGS, INC.
0%
See all $CTTH insider activity →

CTTH sentiment & insider activity

Recent CTTH coverage spans insider activity and corporate actions.

In the last 30 days, CTTH insiders filed 4 SEC Form 4 transactions — 4 purchases ($959) and no sales. The most active reporter was CTT PHARMACEUTICAL HOLDINGS, INC., CEO, with 4 filings.

What's driving CTTH

AlphAI scores every news story that mentions CTTH with an AI model for sentiment and relevance, and aggregates insider trades from CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CTTH

Score
$CTTHLow

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH): Entry into a Material Definitive Agreement

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 8.01 Other Events. CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen cre

Related tickers